North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,310 Jan 1 – Oct 26, 2026
- Disclosed funding
- $252.1B 1915 disclosed amounts
- Median round
- $23.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| Y Provides AI-powered credit card products for consumers | $200M | Undisclosed | Fintech | United States | Investors | |
| P Provides end-to-end technology platform for independent food distributors | $50M | Series CSeries C+ | Foodtech | United States | Investors | |
| PT Produces rare earth metals and alloys for global customers | $40.2M | Series B3Series B | Climate tech | United States | Investors | |
| EW Eagle WirelessCompany profile Provides cellular modules and full-device solutions for IoT and automotive industries Provides cellular modules and full-device solutions for IoT and automotive industries | $30M | Series B | Hardware | United States | Investors | |
| CM Code MetalCompany profile Provides verifiable code translation and optimization for AI and legacy code across platforms Provides verifiable code translation and optimization for AI and legacy code across platforms | $125M | Series B | Defense tech | United States | Investors | |
| TT Ten63 TherapeuticsCompany profile Develops AI-driven drug discovery platform for first- and best-in-class therapeutics Develops AI-driven drug discovery platform for first- and best-in-class therapeutics | $45M | StrategicUndisclosed | AI | United States | Investors | |
| i Provides financing and dining rewards for restaurants and consumers | $450M | Growth | Foodtech | United States | Investors | |
 Altesa BioSciencesCompany profile Clinical-stage developer of oral antiviral medicines for people with chronic lung disease. Clinical-stage developer of oral antiviral medicines for people with chronic lung disease. | $75M | Series B | Biotech | United States | Investors | |
| L LanzaJetCompany profile Develops technology for producing Sustainable Aviation Fuel (SAF) and other alternative fuels Develops technology for producing Sustainable Aviation Fuel (SAF) and other alternative fuels | $47M | Growth | Climate tech | United States | Investors | |
| O OwnwellCompany profile Manages property tax appeals and exemptions for homeowners to reduce tax bills using technology and local expertise Manages property tax appeals and exemptions for homeowners to reduce tax bills using technology and local expertise | $50M | Series B | Proptech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
134rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
98rounds19led - 3General Catalyst
Provision Labs, Tractian, Different
71rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
60rounds0led - 5Khosla Ventures
Arda Industries, Tolan
59rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.